Fowler C J
Med Biol. 1980 Oct;58(5):285-7.
Pretreatment of rat liver homogenates with 1.5 x 10(-4) M SKF 525A is without effect on the activity of monoamine oxidase-A, but results in a decrease in the concentration of clorgyline required for the inhibition of this enzyme form. Such a result is consistent with the hypothesis that rat liver homogenates contain an SKF 525A-sensitive clorgyline-metabolising system.
用1.5×10⁻⁴ M的SKF 525A预处理大鼠肝脏匀浆,对单胺氧化酶-A的活性没有影响,但会导致抑制这种酶形式所需的氯吉兰浓度降低。这样的结果与大鼠肝脏匀浆含有对SKF 525A敏感的氯吉兰代谢系统这一假设相一致。